|
Volumn 58, Issue 3, 2005, Pages 490-491
|
Putamen dopamine transporter and glucose metabolism are reduced in SCA17 [3]
a,b b b c b b b a a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE TRANSPORTER;
FLUORODEOXYGLUCOSE F 18;
GLUCOSE;
N BETA FLUOROPROPYL 2BETA CARBOMETHYL 3BETA (4 IODOPHENYL)NORTROPANE I 123;
NORTROPANE DERIVATIVE;
TRACER;
UNCLASSIFIED DRUG;
ADULT;
CASE REPORT;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DOPAMINERGIC SYSTEM;
GENETIC ANALYSIS;
GLUCOSE METABOLISM;
HUMAN;
LETTER;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PUTAMEN;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SPINOCEREBELLAR ATAXIA TYPE 17;
SPINOCEREBELLAR DEGENERATION;
ADULT;
DNA MUTATIONAL ANALYSIS;
DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS;
GLUCOSE;
HUMANS;
MALE;
POSITRON-EMISSION TOMOGRAPHY;
PUTAMEN;
SPINOCEREBELLAR ATAXIAS;
TATA-BOX BINDING PROTEIN;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 24644471422
PISSN: 03645134
EISSN: None
Source Type: Journal
DOI: 10.1002/ana.20609 Document Type: Letter |
Times cited : (21)
|
References (5)
|